Research programme: kappa opioid receptor agonists - Peptide Logic
Latest Information Update: 28 Sep 2022
At a glance
- Originator Peptide Logic
- Class Analgesics; Antipruritics; Drug conjugates; Peptides; Small molecules
- Mechanism of Action Opioid kappa receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Pain; Pruritus
Most Recent Events
- 28 Sep 2022 No recent reports of development identified for research development in Pain in USA
- 28 Sep 2022 No recent reports of development identified for research development in Pruritus in USA
- 22 Aug 2018 Peptide Logic in-licenses technology for half life extension from Pfizer (Peptide Logic website, August 2018)